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Adverse obstetric outcomes after local treatment for cervical 
preinvasive and early invasive disease according to cone depth: 
systematic review and meta-analysis
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Pierre Martin-Hirsch,4,5 Marc Arbyn,6 Phillip Bennett,1,2 Evangelos Paraskevaidis3 
ABSTRACT
ObjeCtive
To assess the effect of treatment for cervical 
intraepithelial neoplasia (CIN) on obstetric outcomes 
and to correlate this with cone depth and comparison 
group used.
Design
Systematic review and meta-analysis.
Data sOurCes
CENTRAL, Medline, Embase from 1948 to April 2016 
were searched for studies assessing obstetric 
outcomes in women with or without previous local 
cervical treatment.
Data extraCtiOn anD synthesis
Independent reviewers extracted the data and 
performed quality assessment using the Newcastle-
Ottawa criteria. Studies were classified according to 
method and obstetric endpoint. Pooled risk ratios were 
calculated with a random effect model and inverse 
variance. Heterogeneity between studies was 
assessed with I2 statistics.
Main OutCOMe Measures
Obstetric outcomes comprised preterm birth (including 
spontaneous and threatened), premature rupture of 
the membranes, chorioamnionitis, mode of delivery, 
length of labour, induction of delivery, oxytocin use, 
haemorrhage, analgesia, cervical cerclage, and 
cervical stenosis. Neonatal outcomes comprised low 
birth weight, admission to neonatal intensive care, 
stillbirth, APGAR scores, and perinatal mortality.
results
71 studies were included (6 338 982 participants: 
65 082 treated/6 292 563 untreated). Treatment 
significantly increased the risk of overall (<37 weeks; 
10.7% v 5.4%; relative risk 1.78, 95% confidence 
interval 1.60 to 1.98), severe (<32-34 weeks; 3.5% v 
1.4%; 2.40, 1.92 to 2.99), and extreme (<28-30 weeks; 
1.0% v 0.3%; 2.54, 1.77 to 3.63) preterm birth. 
Techniques removing or ablating more tissue were 
associated with worse outcomes. Relative risks for 
delivery at <37 weeks were 2.70 (2.14 to 3.40) for cold 
knife conisation, 2.11 (1.26 to 3.54) for laser conisation, 
2.02 (1.60 to 2.55) for excision not otherwise specified, 
1.56 (1.36 to 1.79) for large loop excision of the 
transformation zone, and 1.46 (1.27 to 1.66) for 
ablation not otherwise specified. Compared with no 
treatment, the risk of preterm birth was higher in 
women who had undergone more than one treatment 
(13.2% v 4.1%; 3.78, 2.65 to 5.39) and with increasing 
cone depth (≤10-12 mm; 7.1% v 3.4%; 1.54, 1.09 to 2.18; 
≥10-12 mm: 9.8% v 3.4%, 1.93, 1.62 to 2.31; ≥15-17 mm: 
10.1% v 3.4%; 2.77, 1.95 to 3.93; ≥20 mm: 10.2% v 
3.4%; 4.91, 2.06 to 11.68). The choice of comparison 
group affected the magnitude of effect. This was higher 
for external comparators, followed by internal 
comparators, and ultimately women with disease who 
did not undergo treatment. In women with untreated 
CIN and in pregnancies before treatment, the risk of 
preterm birth was higher than the risk in the general 
population (5.9% v 5.6%; 1.24, 1.14 to 1.35). 
Spontaneous preterm birth, premature rupture of the 
membranes, chorioamnionitis, low birth weight, 
admission to neonatal intensive care, and perinatal 
mortality were also significantly increased after 
treatment.
COnClusiOns
Women with CIN have a higher baseline risk for 
prematurity. Excisional and ablative treatment further 
increases that risk. The frequency and severity of 
adverse sequelae increases with increasing cone 
depth and is higher for excision than for ablation.
Introduction
The mean age of women undergoing local treatment for 
cervical preinvasive cervical disease (cervical 
 intraepithelial neoplasia or CIN) is similar to the age of 
women having their first child. Local cervical treatment 
WhAT IS AlReAdy knoWn on ThIS TopIC
Local cervical treatment has been associated with an increased risk of preterm 
birth, perinatal morbidity, and mortality in a subsequent pregnancy, which could be 
associated with depth of excision.
Discrepancies exist regarding the impact of treatment on the risk of subsequent 
preterm birth and whether CIN acts as a confounder, which might be caused by 
heterogeneity in comparison groups used in previous studies or different excision 
depths and/or treatment techniques that have been analysed
WhAT ThIS STudy AddS
Increased risk of adverse obstetric outcomes is associated with the treatment 
technique (excision more than ablation) and radicality, determined by the depth 
and dimensions of the cone
Although the risk of preterm birth is higher after local treatment for CIN irrespective 
of the cone depth, the risk increases with increasing cone depth. The increase in 
risk in small excisions compared with just having CIN remains uncertain and is 
likely to be small, if any; more data are required
Choice of comparison group might overinflate or underestimate the effect from 
treatment because of the background increased risk of preterm birth in women with 
CIN. The increased risk of preterm birth, however, remains significantly increased 
after treatment, despite the chosen comparator and even in comparisons with 
women with CIN but no treatment
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has been correlated to an increased risk of preterm 
birth, perinatal morbidity, and mortality in a subse-
quent pregnancy.1-6 The underlying mechanism is 
unclear; hypotheses include immunomodulation relat-
ing to infection with human papillomavirus (HPV) 
affecting parturition pathways and acquired “mechani-
cal weakness” secondary to loss of cervical tissue.7 8
In England alone in 2013-14, about 3.6 million women 
aged 25-64 attended for cervical screening, and over 
23 800 cervical procedures were carried out,9  nearly all 
in an outpatient setting. In contrast, in the United 
States there are about 400 000 cases of preinvasive dis-
ease a year.10  The regulations in colposcopy are more 
liberal, leading to wide variation in clinical practice. In 
Germany, treatment for CIN is still commonly performed 
with the cold knife under general analgesia.11 The long 
term sequelae of treatment therefore remain an import-
ant international issue to healthcare professionals and 
women, whatever the clinical setting.
Since the first systematic review almost a decade ago 
on reproductive risk associated with treatment1  more 
than 50 observational studies have been published con-
firming12 13  or disputing these associations;14 15  some of 
these reported data from large population based data-
sets. Individual attempts to synthesise parts of this rap-
idly evolving evidence base in small systematic reviews 
and meta-analyses reached contradictory conclu-
sions1-4 16-19 and initiated debates and confusion within 
the scientific community.2 16-19 Whether these discrepan-
cies were due to questionable quality of some of these 
primary and secondary studies or to differences in the 
explored comparisons,4 16-18 the subject is open to a 
definitive comprehensive high quality synthesis of the 
existing evidence that will be highly informative to 
women, clinicians, and policy makers.
Media publicity has heightened public awareness 
that treatment for cervical precancer is associated with 
increased reproductive morbidity. There has been a 
substantial increase in inquiries from patients and cli-
nicians on the risks associated with different treatment 
techniques and cone depths20 21 and as to how this risk 
can be managed and prevented. With a rapidly evolving 
evidence base and lack of a robust synthesis of the pub-
lished literature, these questions are becoming increas-
ingly difficult to answer.
We carried out a systematic review and meta-analysis 
to explore the impact of treatment for cervical preinva-
sive and early invasive disease on obstetric outcomes 
and how this risk could be modified by the cone depth 
and comparison group.
Methods
inclusion criteria and outcomes
We included all studies that reported on obstetric out-
comes (over 24 weeks’ gestation) in women who had 
previously received local cervical treatment for CIN or 
early invasive cervical cancer compared with outcomes 
in women with no history of treatment. Studies report-
ing on the outcomes after two or more treatments were 
also included. The interventions included any type of 
treatment: excisional (cold knife conisation; laser 
 conisation; needle excision of the transformation zone, 
also known as straight wire excision; large loop excision 
of the transformation zone, also known as loop electro-
surgical excisional procedure) or ablative (laser abla-
tion; radical diathermy; cold coagulation; and 
cryotherapy). In studies that reported on the impact of 
several techniques, when possible we extracted data for 
each specific method. If the outcomes were not reported 
separately for each technique, we analysed the interven-
tion under broader terms—that is, excisional treatment 
not otherwise specified, ablative treatment not other-
wise specified, and treatment not otherwise specified.
Women were included irrespective of the grade of the 
lesion for both squamous and glandular intraepithelial 
neoplasia. We excluded studies that did not include an 
untreated reference population, compared different 
treatment techniques without an untreated control, or 
compared outcomes for treatments performed during 
pregnancy.
Studies were included irrespective of the type of 
untreated reference population that could have been 
drawn from one of the following sources: external group 
from general population that was mostly matched or 
adjusted for confounders; internal group with self 
matching of the pregnancies for the same women before 
and after treatment; internal group of women who had 
also delivered before treatment; women undergoing col-
poscopy with or without CIN/biopsy but no treatment; 
women with high grade disease but no treatment (high 
grade squamous intraepithelial lesion).
We assessed obstetric outcomes of pregnancies pro-
gressing beyond 24 weeks’ gestation. We examined 
both maternal and neonatal outcomes. The maternal 
outcomes included overall (<37 weeks’ gestation), 
severe (<32-34 weeks), and extreme (<28-30 weeks) pre-
maturity (all preterm birth, iatrogenic and sponta-
neous). We also assessed preterm birth in singleton and 
multiple pregnancies, in nulliparous and parous 
women, for single and repeat cones, for different cone 
depths and volumes, and for different comparison 
groups. We further assessed other maternal outcomes 
that included: overall (<37 weeks’ gestation), severe 
(<32-34), and extreme (<28-30) spontaneous prematurity—
that is, non-iatrogenic); threatened preterm birth; pre-
mature rupture of the membranes; chorioamnionitis; 
mode of delivery (caesarean section, instrumental 
deliveries); length of labour (precipitous, prolonged); 
induction of labour or use of oxytocin; haemorrhage 
(antepartum, postpartum); analgesia (epidural, pethi-
dine, not otherwise specified); cervical stenosis; and 
cervical cerclage. The neonatal outcomes included: low 
birth weight (<2500 g, <2000 g, <1500 g, and <1000 g), 
admission to neonatal intensive unit, perinatal mortal-
ity, stillbirth, and Apgar score.
When there was heterogeneity in the cut offs used in 
different studies for cone depth and classification of 
prematurity, we grouped these together when possible 
(that is, 32-34 weeks included both cut offs; 10-12 mm 
cone depth included studies grouping at both these 
cut offs with and without the values equal to these 
numbers).
the bmj | BMJ 2016;354:i3633 | doi: 10.1136/bmj.i3633
RESEARCH
3
literature search, data extraction, and risk of bias
We searched three electronic databases (CENTRAL, Med-
line, and Embase) and targeted reports published between 
1948 and April 2016. We used keywords including “cervical 
intraepithelial neoplasia (CIN)”, “cervical cancer”, “LLETZ 
or LEEP”, “conisation”, “excision”, “pregnancy”, “obstetric”, 
“preterm birth,” and “prematurity”. The full strategy is 
included in appendix 1. In an attempt to identify any arti-
cles missed by the initial search or any unpublished data, 
we hand searched the references of the retrieved articles 
and meta-analyses and the proceedings of relevant confer-
ences. There was no language restriction.
From each study, we extracted data on the study 
design and setting, the study population, the interven-
tions examined, the comparison group, the quality of 
the data and risk of bias, and the outcomes assessed. 
From each study and for each outcome we retrieved the 
number of events in treated and untreated women. If 
necessary, we contacted authors to obtain additional 
data if the numbers provided in the published report 
did not allow sufficient precision in the data extraction.
We used the Newcastle-Ottawa score to formally 
assess the quality of non-randomised cohort studies,22 
according to the MOOSE checklist.23 This scoring system 
assesses the cohort selection, comparability, and 
assessment of outcomes to give a maximum score of 9 
(highest quality).
Two investigators (MK, AA) independently performed 
the literature search, assessed the eligibility and quality 
of the retrieved papers, and performed the data 
extraction. The two authors then compared the results 
and disagreements were resolved by discussion. If 
required, consensus was reached with the involvement 
of a third investigator (MA).
Data synthesis and assessment of heterogeneity
We calculated the risk ratios and 95% confidence inter-
vals for each reported outcome in the treated versus 
untreated women for dichotomous outcomes using 
Cochrane Revman 5 software. We used a random effect 
model and inverse variance weighting for all meta-anal-
yses.24 In studies with multiple treatment groups, we pro-
portionally divided the “shared” comparison group into 
the number of treatment groups; we treated comparisons 
between each treatment group and the split comparison 
group as independent comparisons. If a study presented 
data for more than one comparison group, we used the 
external comparison group of women with or without 
disease in preference to internal controls. If data were not 
of suitable quality for meta-analysis, we reported the 
results as a narrative in the text of the review.
We assessed heterogeneity between studies with the 
Cochran Q test, visual inspection of forest plots,25 esti-
mation of the percentage of heterogeneity between 
studies that cannot be ascribed to sampling variation 
(I2 statistic),26  and a formal test of the significance for 
 heterogeneity.27 If there was evidence of substantial het-
erogeneity, the possible reasons for this were investi-
gated and reported.
We performed a series of subgroup analyses. We ana-
lysed the data separately for each treatment, in groups 
of ablative and excisional techniques, and as a whole 
irrespective of the type of method used. We further ana-
lysed the data according to the cone depth. Given the 
non-randomised nature of the included studies, we 
assessed whether the choice of comparison group 
affected the risk estimate for each outcome and overin-
flated the effect of treatment that could be partly 
attributed to other confounders. We therefore distin-
guished the different untreated comparison groups used 
across studies and performed subgroup analyses for the 
risk of preterm birth for each individual comparator 
(external; internal (self matching); internal (pregnan-
cies before treatment); colposcopy but no treatment; 
high grade squamous intraepithelial lesion but no treat-
ment). Furthermore, we performed sensitivity analysis 
to assess the impact of the quality of the studies on some 
selected outcomes. We calculated the median score from 
the Newcastle-Ottawa scale and performed sensitivity 
analysis for studies that scored more than the median. 
We performed subgroup analyses based on the cohort 
selection in the Newcastle-Ottawa score (truly or some-
what representative) and the comparability of the 
groups (those with scores of 1 or 2). Finally, we per-
formed meta-regression analysis to assess the impact of 
some factors on the risk of preterm birth (<37 weeks). 
These included the quality of the studies (based on the 
Newcastle-Ottawa score); year of study (1979-89, 1990-
99, 2000-09, 2010-15); type of treatment (excision or 
ablation); type of comparator (external, internal-preg-
nancies before treatment, internal-self matching, CIN 
but no treatment, high grade squamous intraepithelial 
lesion but no treatment).
Patient involvement
Patients and the wider public were involved from the 
outset through informal interviews in the clinic and 
through patient advocate representative bodies. The 
research questions and outcomes were developed 
based on the patients’ concerns and priorities. Patients 
were not involved in the interpretation of results or writ-
ing of the article. The results will be disseminated to the 
lay audience through the authors’ involvement with 
charities and through public presentations.
Results
We identified 406 potentially eligible studies that ful-
filled the inclusion criteria of this review.5 12-15 28-93 No 
unpublished studies were identified. We excluded stud-
ies without an untreated reference population,94-119 
studies that included women treated during preg-
nancy,120 121  studies assessing fertility and early preg-
nancy outcomes below 24 weeks’ gestation,122-127  studies 
assessing outcomes after treatment in high risk popula-
tions,128 129  and studies assessing the impact of CIN on 
outcomes without information as to whether treatment 
was performed.130-132 Figure 1  shows more details of the 
literature search and the reasons for exclusion.133
Table A in appendix 2 shows detailed characteristics of 
the included studies and the outcomes examined. Most 
studies were retrospective, with only five prospective 
reports.71 77-82  All were cohort studies, apart from one 
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case-control study by Castanon and colleagues.85  There 
were no randomised controlled studies. Fourteen studies 
examined the impact of cold knife conisation,13 28-30 32-34 
37 60-62 82 87 89 10 studied laser conisation,42 46 47-49 51 52 56 76 78 
one studied needle excision of the transformation zone.13 
34 studied large loop excision of the transformation 
zone,13 39-41 44 45 50 55-60 62 63 65-69 73 74 76-83 86-88 90 91  eight studied 
laser ablation,35 38 39 47 49 54 56 62  one studied radical dia-
thermy,62  two studied cryotherapy,31 60  16 studied 
excision not otherwise specified,5 12 14 15 53 64 70-72 
 75 78 79 84 85 90 93  five studied ablation not otherwise speci-
fied,12 14 53 70 87  and three studied treatment not otherwise 
specified.36 43 92  There were five types of untreated com-
parison groups. Some used an external comparator,5 12 13-
15 28 29 33 35-4548-55 57-61 64-81 83 86 87 89 92 93  others compared with 
the pregnancies before treatment in the treated popula-
tion (internal)5 15 30-32 34 45-47 58 73 74 84 91  or used self matching 
for women who delivered both before and after treatment 
(internal),13 15 43 48 51 64 66  some compared with women who 
underwent colposcopy with or without CIN and/or 
biopsy but had no treatment,15 56 62 63 67 68 77 81-91 93  and some 
with women with high grade disease but no treat-
ment.13 53 70  All studies that used an external comparison 
group either matched for known risk factors or per-
formed regression analysis to control for known con-
founders; four studies did not control for any 
confounders.43 61 65 76
Table B in appendix 2 provides more details on the 
quality assessment for observational studies with the 
Newcastle-Ottawa score. Most studies scored 8 or 9 
points, 10 scored7 30 35 43 45-47 50 61 72 76  and two scored 6.38 65
Maternal outcomes 
The risk of preterm birth was significantly increased 
after cervical treatment (table 1 ). For all treatment 
types, this was the case for overall prematurity at less 
than 37 weeks’ gestation (relative risk 1.78, 95% confi-
dence interval 1.60 to 1.98), for severe prematurity less 
than 32-34 weeks’ gestation (2.40, 1.92 to 2.99), and 
extreme prematurity less than 28-30 weeks’ gestation 
(2.54, 1.77 to 3.63) (table 1 ). Figure 2 shows the risk asso-
ciated with LLETZ versus no treatment. The forest plot 
in appendix 3 shows the risks for all treatment tech-
niques versus no treatment. The magnitude of the effect 
of treatment was higher for more radical treatment 
techniques and for excision rather than ablation. More 
specifically, the risk of preterm birth at less than 37 
weeks’ gestation was higher for cold knife conisation 
(2.70, 2.14 to 3.40), laser conisation (2.11, 1.26 to 3.54), 
excision not otherwise specified (2.02, 1.60 to 2.55), 
large loop excision of the transformation zone (1.56, 
1.36 to 1.79), and ablation not otherwise specified (1.46, 
1.27 to 1.66). Similar trends were noted for severe and 
extreme prematurity.
Treatment was also associated with an increased risk 
of preterm birth for women with multiple pregnancies 
for some but not all treatments (table C, appendix 2). 
Have asked author, but the results were inconsistent 
because of the small number of studies. The impact of 
treatment was no different for nulliparous and multipa-
rous women (data not shown). The effect of multiple as 
opposed to single treatments on the risk of prematurity 
was substantially higher in comparisons with untreated 
women (relative risk 3.78 (95% confidence interval 2.65 
to 5.39) for repeated treatment and 1.75 (1.49 to 2.06) for 
single treatment, table 2). Compared with no treatment, 
the relative risk of preterm birth for two excisional treat-
ments not otherwise specified was as high as 5.48 (2.68 
to 11.24) and that of two loop excisions as high as 2.81 
(2.33 to 3.39).
The analysis of the risk according to the cone dimen-
sions showed that the risk increases progressively with 
increasing cone depth (table 3 ; fig 3 ) or cone volume 
(table 3 ). The risk for treated versus untreated women 
was significantly higher for women with cone depth 
≤10-12 mm (relative risk 1.54, 95% confidence interval 
1.09 to 2.18). The magnitude of effect increased with 
increasing cone depth (1.93 (1.62 to 2.31) for ≥10-12 mm, 
2.77 (1.95 to 3.93) for ≥15-17 mm, and 4.91 (2.06 to 11.68) 
for ≥20 mm; table 3 ). The trend was similar with 
increasing cone volume (2.25 (1.09 to 4.66) for ≤6 cc and 
13.9 (5.09 to 37.98) for ≥6 cc; table 3). Further analyses of 
the individual cone depth cut offs not grouped together 
showed similar results (data not shown).
The comparison of women treated with different cone 
depths showed that deeper excisions significantly 
increased the risk of preterm birth compared with less 
deep excisions, and the magnitude of the effect 
increased in deeper cones. The relative risk were 1.54 
(95% confidence interval 1.31 to 1.80) for ≥10-12 mm v 
≤10-12 mm, 1.82 (1.47 to 2.26) for ≥15-17 mm v ≤15-17 mm, 
and 1.82 (1.47 to 2.26) for ≥20 mm v ≤20 mm (fig 4). Full 
data are also provided in table D, appendix 2. The findings 
were similar for the comparison of cone volumes (2.04 
(0.95 to 4.39) for ≥3-4 cc v ≤3-4 cc (15.0% v 7.3%, one 
study, 278 women); 6.18 (2.53 to 15.13) for ≥6 cc v ≤6 cc 
(50.0% v 8.1%, one study, 278 women).
We assessed the impact that the choice of compari-
son group can have on the magnitude of effect in a sub-
group analysis that classified different studies 
according to the comparator used (table 4). The results 
suggested that treatment significantly increased the 
Citations identied in literature search (n=3021)
Citations retrieved for more detailed evaluation (n=406)
Studies included (n=71)
Citations excluded based on title or abstract (n=2615)
Excluded (n=335):
  No untreated comparison group (n=56)
  High risk treated and/or comparison group (n=2)
  CIN (no details on treated women, see text) (n=3)
  Treatment during pregnancy (n=6)
  No data on obstetric outcomes of interest (n=18)
  Review/systematic review/meta-analysis (n=79)
  Conference proceedings (n=103)
  Letters (n=53)
  Duplicates (n=7)
  In other than English language (n=8)
Fig 1 | identification of studies to include in analysis of 
adverse obstetric outcomes after local treatment for 
cervical preinvasive and early invasive disease
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risk of preterm birth at less than 37 weeks’ gestation 
irrespective of the comparison group used. The magni-
tude of effect was higher when an external comparison 
group was used (relative risk 1.93, 95% confidence inter-
val 1.71 to 2.17), followed by internal comparators (1.52 
(1.17 to 1.97) for self matching and 1.42 (1.01 to 1.99) for 
pregnancies before treatment), and ultimately women 
with disease but no treatment (1.27, 1.14 to 1.41). In 
women with untreated CIN, and in pregnancies before 
treatment, the risk of preterm birth compared with gen-
eral population was significantly higher (1.24, 1.14 to 
1.35). The subgroup analysis of the risk of preterm birth 
according to cone depth and comparison group showed 
a similar direction of effect, although for cone depth ≤10-
12 mm the difference became insignificant. The number 
of studies was small for many comparisons. For treated 
versus untreated women with CIN there were four stud-
ies for cone depth ≤10-12 mm (43 145 women, 7.0% v 
5.0%, relative risk 1.11, 95% confidence interval 0.85 to 
1.43), four studies for cone depth ≥10-12 mm (45 275 
women, 9.6% v 5.0%, 1.52, 1.37 to 1.68), three studies for 
cone depth ≥15-17 mm (33 934 women, 9.6% v 4.3%, 2.30, 
1.57 to 3.35), and two studies for cone depth ≥20 mm 
(32 717 women, 9.3% v 4.2%, 4.32, 0.93 to 20.03) (table E, 
appendix 2). Furthermore, the sensitivity  analysis that 
excluded studies that scored below the median Newcas-
tle-Ottawa score (8.3) did not change the results of the 
analysis; similarly the results did not change when we 
excluded studies that scored ≤7 and ≤6 (data not shown). 
The subgroup analyses of studies based on the cohort 
selection or the comparability of the comparison groups 
showed similar direction and magnitude of effect (data 
not shown). The univariate meta-regression analysis 
suggested that the type of treatment and comparator sig-
nificantly affected the risk of preterm birth, although the 
type of treatment and Newcastle-Ottawa score did not. 
These factors remained significant in a multivariate 
regression analysis. When we performed further 
meta-regression restricting only to excisional treatments 
and using as a comparator women with colposcopy/
biopsy, we found that all treatments were associated 
with an increased risk of preterm birth (1.34, 1.10 to 1.64, 
for large loop excision of the transformation zone; 2.3, 
1.39, 3.85, for cold knife conisation; 1.6, 0.91 to 2.87, for 
laser conisation; and 4.26, 1.96 to 9.33, for needle exci-
sion of the transformation zone).
Several studies assessed other adverse maternal 
 outcomes (table F, appendix 2), and many of these 
were  found to be increased after cervical treatment. 
This  increase was more commonly associated with 
table 1 | Preterm birth in women with cervical intraepithelial neoplasia (Cin) for treated versus untreated women*
Preterm birth no of studies
total no of 
women
no (%) of women effect estimate rr 
(95% Ci)
P value for 
heterogeneity (i2%)treated untreated
<37 weeks’ gestation
All treatment types 60 5 244 560 6506/60 619 (10.7) 281 575/5 183 941 (5.4) 1.78 (1.60 to 1.98) <0.001 (88)
CKC 12 39 102 126/844 (14.9) 2321/38 258 (6.1) 2.70 (2.14 to 3.40) 0.62 (0)
LC 9 1464 96/672 (14.3) 58/792 (7.3) 2.11 (1.24 to 3.57) 0.02 (56)
NETZ 1 7399 17/71 (23.9) 301/7328 (4.1) 5.83 (3.80 to 8.95) N/E
LLETZ 26 1 445 341 1724/21 318 (8.1) 66 607/1 424 023 (4.7) 1.56 (1.36 to 1.79) <0.001 (69)
LA 7 4710 168/1867 (9.0) 242/2843 (8.5) 1.04 (0.86 to 1.26) 0.48 (0)
CT 2 238 4/151 (2.6) 2/87 (2.3) 1.02 (0.22 to 4.77) 0.67 (0)
RD 1 2150 109/760 (14.3) 123/1390 (8.8) 1.62 (1.27 to 2.06) N/E
Excisional treatment NOS 15 3 107 438 3788/28 104 (13.4) 183 133/3 079 334 (5.9) 2.02 (1.60 to 2.55) <0.001 (95)
Ablative treatment NOS 5 595 272 430/6482 (6.6) 26 804/588 790 (4.6) 1.46 (1.27 to 1.66) 0.22 (30)
Treatment NOS 3 41 401 44/350 (12.6) 1979/41 051 (4.8) 2.20 (1.28 to 3.78) 0.07 (62)
<32-34 weeks’ gestation
All treatment types 25 3 795 351 1375/39 647 (3.5) 53 835/3 755 704 (1.4) 2.40 (1.92 to 2.99) <0.001 (82)
CKC 5 36 979 15/283 (5.3) 920/36 696 (2.5) 3.07 (1.72 to 5.49) 0.65 (0)
NETZ 1 7399 5/71 (7.0) 49/7328 (0.7) 10.53 (4.33 to 25.65) N/E
LLETZ 11 791 554 237/11 569 (2.0) 9504/779 985 (1.2) 2.13 (1.66 to 2.75) 0.08 (40)
CT 1 58 1/36 (2.8) 0/22 (0.0) 1.86 (0.08 to 43.87) N/E
Excisional treatment NOS 10 2 832 112 1000/22 562 (4.4) 42 598/2 809 550 (1.5) 3.05 (1.95 to 4.78) <0.001 (91)
Ablative treatment NOS 2 120 762 26/2549 (1.0) 686/118 213 (0.6) 1.59 (1.08 to 2.35) 0.92 (0)
Treatment NOS 2 6487 91/2577 (3.5) 78/3910 (2.0) 1.65 (1.13 to 2.42) 0.25 (24)
<28-30 weeks’ gestation
All treatment types 9 3 912 106 403/39 154 (1.0) 12 887/3 872 952 (0.3) 2.54 (1.77 to 3.63) <0.001 (81)
CKC 2 7118 2/150 (1.3) 19/6968 (0.3) 4.52 (0.83 to 24.54) 0.74 (0)
NETZ 1 7399 3/71 (4.2) 21/7328 (0.3) 14.74 (4.50 to 48.32) N/E
LLETZ 3 502 778 59/8899 (0.7) 1224/493 879 (0.2) 2.57 (1.97 to 3.35) 0.9 (0)
Excisional treatment NOS 4 2 821 185 287/21 984 (1.3) 9854/2 799 201 (0.4) 2.90 (1.52 to 5.52) <0.001 (88)
Ablative treatment NOS 3 568 217 23/6125 (0.4) 1739/562 092 (0.3) 1.38 (0.81 to 2.36) 0.21 (35)
Treatment NOS 1 5409 29/1925 30/3484 1.75 (1.05 to 2.91) N/E
CKC=cold knife conisation; CT=cryotherapy; LA=laser ablation; LC=laser conisation; LLETZ=large loop excision of transformation zone; N/E=not eligible; NETZ=needle excision of 
transformation zone; NOS=not otherwise specified; RD=radical diathermy.
*If study had more than one comparison groups, we used external groups (external general, external untreated women who had colposcopy+/-CIN+/-biopsy, women with HSIL but no 
treatment) in preference to internal comparators (self matching or pregnancies before treatment).
†In cases of heterogeneity in cut-offs used for classification of prematurity, these were grouped together when possible (for instance, 32-34 or 28-30 weeks included both cut offs).
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 excisional than ablative techniques and with more rad-
ical treatment, although the number of studies assess-
ing each individual treatment method was often small. 
Cervical treatment was associated with an increased 
risk of spontaneous overall, severe, and extreme 
preterm birth (<37 weeks: 14 studies, 1 024 731 women, 
7.0% v 3.7%; relative risk 1.76, 95% confidence interval 
1.47 to 2.11; <32-34 weeks: seven studies, 655 675 women, 
1.8% v 0.6%; 2.63, 1.91 to 3.62; <28 weeks: two studies, 
626 670 women, 0.6% v 0.2%, 3.18, 1.64 to 6.16) and 
admissions for threatened preterm birth (five studies, 
903 women, 9.1% v 3.2%, 2.44, 1.37 to 4.33). The risk (<37 
weeks) was higher for cold knife conisation (3.53, 2.05 to 
6.05) followed by excision not otherwise specified (1.70, 
1.17 to 2.46), large loop excision of the transformation 
zone (1.60, 1.22 to 2.08), and ablation not otherwise 
specified (1.42, 1.20 to 1.70). Needle excision of the 
transformation zone and laser ablation were each 
assessed in only one study. There was substantial het-
erogeneity for the comparisons assessing all gestational 
categories (P<0.05).
The risk of premature rupture of membranes (<37 
weeks: 21 studies, 477 011 women; 6.1% v 3.4%, relative 
risk 2.36, 95% confidence interval 1.76 to 3.17) and cho-
rioamnionitis (four studies, 29 198 women, 3.5 v 1.1%; 
3.43, 1.36 to 8.64) was also increased after treatment. 
Risk was higher after cold knife conisation (4.11, 2.05 to 
8.25) followed by large loop excision of the transforma-
tion zone (2.15, 1.48 to 3.12). Needle excision of the 
transformation zone was assessed in only one study, 
and laser ablation did not significantly affect the risk 
but was assessed in only two studies.
The mode of delivery (caesarean section or instrumen-
tal delivery), the length of labour (precipitous or pro-
longed), the use of analgesia (epidural, pethidine, or 
other), the rate of induction of labour (with or without 
oxytocin), cervical stenosis, and haemorrhage (antenatal 
or postpartum) were not affected by treatment. As 
expected, the rate of cervical cerclage insertion was 
higher for treated than non-treated women (eight studies, 
141 300 women, 4.0% v 0.7%, relative risk 14.29, 95% con-
fidence interval 2.85 to 71.65) and more so for cold knife 
conisation (31.42, 2.32 to 426.2), large loop excision of the 
transformation zone (11.0, 0.64 to 190), or excisional treat-
ment not otherwise specified (42.45, 28.99 to 62.16).
neonatal outcomes
More than 30 studies assessed one or more neonatal out-
comes (table G, appendix 2). Cervical treatment (exci-
sional or ablative) was associated with a significant 
  Gunasekera 1992
  Blomeld 1993
  Haenden 1993
  Braet 1994
  Cruickshank 1995
  Paraskevaidis 2002
  Sadler 2004
  Tan 2004
  Samson 2005
  Acharya 2005
  Crane 2006
  Himes 2007
  Bruinsma 2007
  Noehr 2009 (singletons and cone depth)
  Werner 2010
  Orto 2010
  Andia 2011
  Lima 2011
  Simoens 2012
  Poon 2012
  Frega 2013
  Heinonen 2013
  Frey 2013 
  Guo 2013
  Martyn 2015
  Stout 2015
Total (95% CI)
Test for heterogeneity: τ2=0.05, χ2=78.52, df=24, P<0.001, I2=69%
Test for overall eect: z=6.38, P<0.001
Not estimable
1.56 (0.62 to 3.87)
1.07 (0.54 to 2.14)
2.50 (0.82 to 7.63)
1.87 (0.93 to 3.78)
3.67 (1.14 to 11.75)
1.29 (0.86 to 1.93)
1.18 (0.55 to 2.53)
3.14 (1.74 to 5.67)
1.06 (0.49 to 2.27)
6.13 (0.81 to 46.36)
0.73 (0.41 to 1.31)
1.81 (0.83 to 3.96)
1.91 (1.75 to 2.07)
0.94 (0.69 to 1.30)
2.34 (1.82 to 3.02)
1.90 (0.91 to 3.98)
4.00 (0.81 to 19.82)
4.00 (1.59 to 10.05)
1.93 (1.43 to 2.60)
1.28 (0.72 to 2.27)
1.56 (1.44 to 1.70)
1.19 (0.96 to 1.47)
1.02 (0.44 to 2.32)
2.29 (0.94 to 5.60)
1.22 (0.99 to 1.51)
1.56 (1.36 to 1.79)
--
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9/80
14/152
4/78
15/295
3/28
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11/119
14/558
17/158
1/46
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17 445/240 348
2426/59 065
10/189
2/36
6/104
1156/25 772
19/379
30151/658 179
178/1140
8/39
6/191
178/1129
66 607/1 424 023
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Fig 2 | Meta-analysis of studies on preterm birth (<37 weeks) in women treated with large loop excision of transformation 
zone versus untreated women
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increase in adverse neonatal outcomes compared with 
outcomes in women who did not undergo treatment 
(comparison group not specified). The association with 
adverse neonatal events was stronger and more com-
mon for excisional rather than ablative techniques and 
with increasing treatment radicality, although the num-
ber of studies for each individual treatment technique 
was often limited.
More specifically, cervical treatment overall was 
associated with an increased risk of low birth weight 
(<2500 g: 30 studies, 1 348 206 women, 7.9% v 3.7%, rel-
ative risk 1.81, 95% confidence interval 1.58 to 2.07; 
<1500 g: five studies, 76 836 women, 2.0% v 0.5%, 3.00, 
1.54 to 5.85), admission to a neonatal intensive unit 
(eight studies, 2557 women, 12.6% v 8.9%, 1.45, 1.16 to 
1.81), and perinatal mortality (23 studies, 1 659 433 
women, 0.9% v 0.7%, 1.51, 1.13 to 2.03). There was signif-
icant heterogeneity between studies for perinatal mor-
tality (P=0.04, I2=36%).
The rate of neonates with birth weight <2500 g was sig-
nificantly higher for women treated with cold knife coni-
sation (five studies, 30 304, relative risk 2.51, 95% 
confidence interval 1.78 to 3.53), large loop excision of the 
transformation zone (12 studies, 3357, 2.11, 1.51 to 2.94), 
excisional (10 studies, 823 648, 2.01, 1.62 to 2.49) or abla-
tive (four studies, 483 402, 1.36, 1.19 to 1.55)  treatment not 
otherwise specified but not so for laser ablation (1.07, 0.59 
to 1.92), although for that comparison there were only 
four studies with a total of 1104 participants. The rate of 
admission to neonatal intensive care was assessed only 
for excisional techniques and was significantly increased 
after large loop excision of the transformation zone (five 
studies, 1994 women, 1.42, 1.01 to 1.99). Perinatal mortal-
ity was significantly increased overall and for excisional 
technique not otherwise specified (five studies, 820 028, 
1.85, 1.02 to 3.36) but not for the individual techniques, 
possibly because of the limited number of studies and 
the low prevalence of the outcome. Subgroup analysis 
according to the different comparison groups or cone 
depths was not possible because of the limited number 
of studies assessing each outcome.
discussion
Main findings
The knowledge that local treatment for cervical precan-
cer, particularly excisional, increases the risk of preterm 
birth has led to major changes in clinical practice. With a 
rapidly evolving evidence base and inconsistencies in 
the published literature,14 15 17 18 66 113 a high quality synthe-
sis of the evidence should be available for effective coun-
selling of patients at colposcopy and antenatal clinics.
This meta-analysis shows that any local cervical 
treatment for preinvasive or early invasive disease 
increases the risk of preterm birth and adverse sequelae 
in a subsequent pregnancy, although the impact of 
small excisions, as opposed to just having the disease, 
remains uncertain and is likely to be small. Cervical 
treatment was found to be associated with an increased 
risk of overall, severe, and extreme prematurity, spon-
taneous preterm birth, threatened preterm labour, pre-
mature rupture of the membranes, chorioamnionitis, 
low birth weight, neonatal admission, and perinatal 
death. The rate of cervical cerclage was unsurprisingly 
substantially increased in treated women compared 
with untreated controls. Treatment equally affected out-
comes for nulliparous as well as parous women and 
singleton and multiple pregnancies. The mode of deliv-
ery, length of labour, induction rate, use of analgesia, 
rate of stenosis, and haemorrhage were not signifi-
cantly affected.
table 2 | Preterm birth (<37 weeks’ gestation) in women with cervical intraepithelial neoplasia (Cin) for treated versus untreated women according to 
number of treatments*
no of studies
total no of 
women
no (%) of women effect estimate rr 
(95% Ci)
P value for 
heterogeneity (i2%)treated untreated
single treatment
All treatment types 17 1 367 023 1519/20 302 (7.5) 56 185/1 346 721 (4.2) 1.75 (1.49 to 2.06) <0.001 (79)
CKC 3 36 783 38/179 (21.2) 2250/36604 (6.1) 2.89 (2.08 to 4.03) 0.42 (0)
LC 2 657 34/335 (10.1) 29/322 (9.0) 1.06 (0.54 to 2.09) 0.17 (48)
NETZ 1 7399 17/71 (23.9) 301/7328 (4.1) 5.83 (3.80 to 8.95) N/E
LLETZ 9 1 277 874 1139/16 755 (6.8) 51 075/1 261 119 (4.0) 1.74 (1.45 to 2.10) <0.001 (75)
LA 4 1421 58/624 (9.3) 68/797 (8.5) 1.07 (0.66 to 1.74) 0.17 (40)
Excisional treatment NOS 3 32 106 197/1816 (10.8) 1840/30 290 (6.1) 1.88 (1.20 to 2.93) 0.1 (57)
Ablative treatment NOS 1 10 783 36/522 (6.9) 622/10 261 (6.1) 1.14 (0.82 to 1.57) N/E
repeat treatment
All treatment types 11 1 317 284 191/1442 (13.2) 54 142/1 315 842 (4.1) 3.78 (2.65 to 5.39) <0.001 (75)
CKC/LA 1 99 2/2 (100.0) 6/97 (6.2) 12.56 (5.11 to 30.87) N/E
LC/LC 1 270 6/20 (30.0) 20/250 (8.0) 3.75 (1.70 to 8.27) N/E
LLETZ/LLETZ 4 1 202 174 139/1195 (11.6) 48 586/1 200 979 (4.0) 2.81 (2.33 to 3.39) 0.35 (9)
LLETZ/treatment NOS 1 298 9/41 (22.0) 6/257 (2.3) 9.40(3.53 to 25.03) N/E
Excisional NOS/excisional 
treatment NOS
3 73 651 17/57 (29.8) 3034/73 594 (4.1) 5.48 (2.68 to 11.24) 0.16 (45)
Treatment NOS/treatment 
NOS
2 40 792 18/127 (14.2) 2490/40 665 (6.1) 1.71 (1.10 to 2.67) 0.85 (0)
CKC=cold knife conisation; CT=cryotherapy; LA=laser ablation; LC=laser conisation; LLETZ=large loop excision of transformation zone; N/E=not eligible; NETZ=needle excision of transformation 
zone; NOS=not otherwise specified; RD=radical diathermy.
*If study had more than one comparison groups, we used external groups (external general, external untreated women that had colposcopy+/−CIN+/−biopsy, women with HSIL but no 
treatment) in preference to internal comparators (self matching or pregnancies before treatment).
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The magnitude of the effect of treatment was higher 
for more radical techniques (such as cold knife conisa-
tion followed by large loop excision of the transforma-
tion zone and laser ablation) and for excision rather than 
ablation. Multiple conisations increased the risk 
of preterm birth fourfold compared with untreated con-
trols overall. Subgroup analyses clearly showed that the 
risk of preterm birth is directly correlated with the cone 
dimensions (depth/volume) and progressively increases 
with increasing cone depth (“dose effect”). Although the 
risk was increased even for excisions less than 10 mm in 
depth, this was almost twofold for excisions of more 
table 3 | Preterm birth (<37 weeks’ gestation) in women with cervical intraepithelial neoplasia (Cin) for treated versus untreated women according to 
cone depth and volume
no of studies
total no of 
women
no (%) of women effect estimate rr 
(95% Ci)
P value for 
heterogeneity (i2%)treated untreated
Cone depth
≤10-12 mm
All treatment types 8 550 929 293/4105 (7.1) 18 720/546 824 (3.4) 1.54 (1.09 to 2.18) 0.004 (67)
LC 1 105 1/41 (2.4) 3/64 (4.7) 0.52 (0.06 to 4.83) N/E
LLETZ 3 544 907 98/1600 (6.1) 18 448/543 307 (3.4) 2.01 (1.28 to 3.15) 0.13 (51)
Excisional treatment NOS 4 5917 194/2464 (7.9) 269/3453 (7.8) 1.20 (0.78 to 1.85) 0.15 (44)
≥10-12 mm
All treatment types 8 552 711 571/5845 (9.8) 18 723/546 866 (3.4) 1.93 (1.62 to 2.31) 0.13 (37)
LC 1 87 5/23 (21.7) 3/64 (4.7) 4.64 (1.20 to 17.88) N/E
LLETZ 3 546 134 193/2827 (6.8) 18 448/543 307 (3.4) 2.29 (1.57 to 3.34) 0.2 (37.23)
Excisional treatment NOS 4 6490 373/2995 (12.5) 272/3495 (7.8) 1.68 (1.41 to 1.99) 0.37 (5.32)
≤15-17 mm
All treatment types 4 545 939 149/2614 (5.7) 18 493/543 325 (3.4) 1.36 (1.15 to 1.61) 0.61 (0)
LC 1 164 0/14 (0.0) 7/150 (4.7) 0.67 (0.04 to 11.18) N/E
LLETZ 2 545 119 117/2370 (4.9) 18 434/542 749 (3.4) 1.42 (1.18 to 1.70) 0.41 (0)
Excisional treatment NOS 1 656 32/230 (13.9) 52/426 (12.2) 1.14 (0.76 to 1.72) N/E
≥15-17 mm
All treatment types 4 544 986 167/1661 (10.1) 18 493/543 325 (3.4) 2.77 (1.95 to 3.93) 0.1 (53)
LC 1 211 14/61 (23.0) 7/150 (4.7) 4.92 (2.09 to 11.59) N/E
LLETZ 2 544 248 128/1499 (8.5) 18 434/542 749 (3.4) 3.16 (1.54 to 6.48) 0.08 (67)
Excisional treatment NOS 1 527 25/101 (24.8) 52/426 (12.2) 2.03 (1.33 to 3.10) N/E
≤20 mm
All treatment types 3 545 992 174/3093 (5.6) 18 441/542 899 (3.4) 1.60 (1.38 to 1.87) 0.62 (0)
LC 1 183 2/33 (6.1) 7/150 (4.7) 1.30 (0.28 to 5.97) N/E
LLETZ 2 545 809 172/3060 (5.6) 18 434/542 749 (3.4) 1.61 (1.38 to 1.87) 0.35 (0)
≥20 mm
All treatment types 3 543 750 87/851 (10.2) 18441/542 899 (3.4) 4.91 (2.06 to 11.68) 0.01 (77)
LC 1 192 12/42 (28.6) 7/150  (4.7) 6.12 (2.57 to 14.57) N/E
LLETZ 2 543 558 75/809 (9.3) 18 434/542 749 (3.4) 4.72 (1.25 to 17.80) 0.01 (83)
10-13 to 15-16 mm
All treatment types 3 544 534 75/1359 (5.5) 18 486/543 175 (3.4) 1.32 (1.04 to 1.66) 0.82 (0)
LLETZ 2 543 994 57/1245 (4.6) 18 434/542 749 (3.4) 1.32 (1.02 to 1.72) 0.53 (0)
Excisional treatment NOS 1 540 18/114 (15.8) 52/426 (12.2) 1.29 (0.79 to 2.12) N/E
15-16 to 19-20 mm
All treatment types 3 543 608 55/709 (7.8) 18441/542 899 (3.4) 2.24 (1.73 to 2.91) 0.42 (0)
LC 1 169 2/19 (10.5) 7/150 (4.7) 2.26 (0.50 to 10.08) N/E
LLETZ 2 543 439 53/690 (7.7) 18 434/542 749 (3.4) 2.53 (1.42 to 4.51) 0.19 (43)
Cone volume
<3 cc
All treatment types 1 496 16/218 (7.3) 10/278 (3.6) 2.04 (0.94 to 4.41) N/E
LLETZ 1 496 16/218 (7.3) 10/278 (3.6) 2.04 (0.94 to 4.41) N/E
>3 cc
All treatment types 1 338 9/60 (15.0) 10/278 (3.6) 4.17 (1.77 to 9.82) N/E
LLETZ 1 338 9/60 (15.0) 10/278 (3.6) 4.17 (1.77 to 9.82) N/E
<6 cc
All treatment types 1 550 22/272 (8.1) 10/278 (3.6) 2.25 (1.09 to 4.66) N/E
LLETZ 1 550 22/272 (8.1) 10/278 (3.6) 2.25 (1.09 to 4.66) N/E
>6 cc
All treatment types 1 284 3/6 (50.0) 10/278 (3.6) 13.9 (5.09 to 37.98) N/E
LLETZ 1 284 3/6 (50.0) 10/278 (3.6) 13.9 (5.09 to 37.98) N/E
3-6 cc
All treatment types 1 332 6/54 (11.1) 10/278 (3.6) 3.09 (1.17 to 8.14) N/E
LLETZ 1 332 6/54 (11.1) 10/278 (3.6) 3.09 (1.17 to 8.14) N/E
LC=laser conisation; LLETZ=large loop excision of transformation zone; N/E=not eligible; NETZ=needle excision of transformation zone; NOS=not otherwise specified.
*In cases of heterogeneity in cut offs used for classification of cone depth, these were grouped together when possible (for instance, 10-12 mm in depth included studies using either cut off 
≥11-12 or ≤11-12 mm as some studies included depths equal to cut off and others did not).
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than 10 mm, threefold for more than 15-17 mm, and 
almost fivefold for excisions exceeding 20 mm in depth.
It has previously been suggested that the impact of 
treatment on the risk of preterm birth might not be a 
consequence of treatment but rather a product of other 
confounders present in women with cervical dis-
ease.7 14 15 Our subgroup analyses that stratified the risk 
by the comparator used, clearly documents that 
although the risk of preterm birth is significantly 
increased after treatment irrespective of the comparison 
group used, the choice of comparator might overinflate 
or underestimate the effect from treatment. The magni-
tude of effect was higher when we used external con-
trols, followed by internal controls, followed by women 
who had disease but were not treated. The analyses in 
women with high grade squamous intraepithelial lesion 
but no treatment only included three studies and 3764 
participants; we were unable to draw any firm conclu-
sions from this comparison. When we assessed the risk 
of preterm birth according to both the cone depth and 
comparator, we noted overall the same direction of 
effect. Although the difference in the risk of preterm 
birth for small excisions (≤10-12 mm) compared with 
just having CIN but no treatment, became insignificant, 
the number of studies assessing that comparison was 
small, and we cannot draw firm conclusions.
Our results also confirm that although women with 
CIN have a higher baseline risk of prematurity than the 
general population, cervical treatment, and particu-
larly deep cones, further increase that risk.
strengths and limitations
This is the first systematic review to show that any local 
cervical treatment technique (excisional or destructive) 
Cone depth ≤10-12 in treated patients
  Raio 1997
  Sadler 2004
  Samson 2005
  Noehr 2009 (singletons and cone depth)
  Lima 2011
  Simoens 2012
  Castanon 2012 and 2014
  Kitson 2014
Total (95% CI)
Test for heterogeneity: τ2=0.12, χ2=20.93, df=7, P=0.004, I2=67%
Test for overall eect: z=2.46, P=0.01
Cone depth ≥10-12 in treated patients
  Raio 1997
  Sadler 2004
  Samson 2005
  Noehr 2009 (singletons and cone depth)
  Lima 2011
  Castanon 2012 and 2014
  Simoens 2012
  Kitson 2014
Total (95% CI)
Test for heterogeneity: τ2=0.02, χ2=11.09, df=7, P=0.13, I2=37%
Test for overall eect: z=7.19, P<0.001
Cone depth ≥15-17 in treated patients
  Andersen 1999
  Sadler 2004
  Noehr 2009 (singletons and cone depth)
  Kitson 2014
Total (95% CI)
Test for heterogeneity: τ2=0.06, χ2=6.36, df=3, P=0.01, I2=53%
Test for overall eect: z=5.71, P<0.001
Cone depth ≥20 in treated patients
  Andersen 1999
  Noehr 2009 (singletons and cone depth)
  Kitson 2014
Total (95% CI)
Test for heterogeneity: τ2=0.44, χ2=8.88, df=2, P<0.001, I2=77%
Test for overall eect: z=3.59, P<0.001
0.52 (0.06 to 4.83)
0.99 (0.57 to 1.72)
3.02 (1.65 to 5.53)
1.56 (1.20 to 2.02)
5.16 (1.29 to 20.60)
1.50 (0.36 to 6.21)
1.04 (0.86 to 1.26)
2.16 (0.88 to 5.32)
1.54 (1.09 to 2.18)
4.64 (1.20 to 17.88)
1.64 (1.13 to 2.37)
3.84 (1.66 to 8.88)
1.93 (1.66 to 2.23)
2.76 (0.51 to 14.99)
1.61 (1.37 to 1.91)
3.43 (1.45 to 8.13)
2.70 (1.27 to 5.76)
1.93 (1.62 to 2.31)
4.92 (2.09 to 11.59)
2.03 (1.33 to 3.10)
2.41 (2.03 to 2.87)
5.21 (2.23 to 12.16)
2.77 (1.95 to 3.93)
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Fig 3 | Preterm birth (<37 weeks) in women treated for Cin according to cone depth (≤10-12 mm, ≥10-12 mm, ≥15-17 mm, 
≥20 mm) versus untreated women
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is associated with an increased risk of preterm birth and 
adverse obstetric sequelae and to document that the risk 
directly correlates to the cone depth (and volume), the 
treatment technique (excision more than ablation), and 
radicality. This meta-analysis included a large number 
of studies (71 cohorts) with sufficient sample size and 
power to explore several comparisons of treatment tech-
niques and cone depths. Furthermore, we were able to 
perform subgroup analyses according to the comparator 
used and quantify the risk in different clinical groups.
The results, however, should be interpreted with cau-
tion. Because of the premalignant nature of the disease, 
no randomised studies could be identified. All the 
included studies were cohorts, nearly all retrospective. 
Such reports are at known risk of recall bias and inade-
quate adjustment for known and unknown confound-
ers, while some of the outcomes of interest were difficult 
to measure objectively. Many of the studies relied on 
data collected from structured interviews and mailed 
questionnaires, and in some of these the response rate 
was small, also increasing the risk of incomplete out-
come data (attrition) and misclassification bias. The 
studies often had different designs and used compari-
sons between and among women and mixed matching. 
Although the overall number of studies was large, for 
some outcomes and comparisons there were few stud-
ies, and the analyses did not have sufficient sample 
sizes to support definite conclusions.
Although heterogeneity between studies was not sig-
nificant for most of the analyses, some subgroup analyses 
did show variation in the outcomes across studies. This 
was often in analyses that included small number of stud-
ies and participants. Meta-regression was possible for 
some but not all possible confounders. For many moder-
ators, data were reported only in a proportion of the 
included studies. When these studies were not deemed 
representative of the whole population of studies, we did 
not perform meta-regression as this would introduce bias. 
Sensitivity and subgroups analyses based on study qual-
ity did not change the effect of the meta-analysis.
There were further limitations in the interpretation of 
the data. The gestational age cut offs used for the defini-
tions of severe and extreme prematurity and for differ-
ent cone depths varied slightly across studies; we 
merged these in broader groups for the analysis. Indi-
vidual patient meta-analysis data are required to more 
accurately describe the stratified risk of preterm birth 
for individual cone depths. The data on cone dimen-
sions relied on retrospective data recorded in histopa-
thology reports of formalin fixed samples, with obvious 
limitations. The formulas used for the calculation of 
volume also varied across studies. Future research 
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Fig 4 | Preterm birth (<37 weeks’ gestation) in women treated for Cin according to cone depth
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should aim to correlate outcomes with precise prospec-
tive cone depth and cervical measurements.
Both the included and excluded studies showed a 
wide range of inclusion/exclusion criteria and outcome 
measures limiting statistical pooling of all the primary 
studies. There should be agreement among colposco-
pists and obstetricians on core research clinical out-
come measures in line with the CROWN initiative of the 
premier reproductive health journals.134 This would 
improve the applicability of findings of primary and 
secondary research internationally.
interpretation in light of other evidence
With an increasing evidence base suggesting that this 
risk is higher for more radical techniques, there has been 
a tendency to use less aggressive treatments.5  Although 
it was previously thought that the various techniques 
had comparable efficacy,135  evidence from a population 
table 4 | Preterm birth (<37 weeks’ gestation) in women with cervical intraepithelial neoplasia (Cin) for treated and untreated women according to 
comparison group
Comparison no of studies
total no of 
women
no (%) of women effect estimate rr 
(95% Ci)
P value for 
heterogeneity (i2%)treated untreated
all treatment types v untreated external
Overall 46 5 193 761 5888/55 799 (10.6) 278 963/5 137 962 (5.4) 1.93 (1.71 to 2.17) <0.001 (90)
CKC 7 37 370 62/390 (15.9) 2263/36 980 (6.1) 3.28 (2.44 to 4.42) 0.99 (0)
LC 6 1126 68/480 (14.2) 46/646 (7.1) 2.39 (1.24 to 4.61) 0.02 (63)
NETZ 1 7361 17/71 (23.9) 300/7290 (4.1) 5.82 (3.79 to 8.94) N/E
LLETZ 20 1 415 006 1513/19 934 (7.6) 65 080/1 395 072 (4.7) 1.69 (1.46 to 1.97) <0.001 (68)
LA 4 1258 37/510 (7.3) 50/748 (6.7) 1.27 (0.67 to 2.4) 0.19 (38)
CT 1 58 1/36 (2.8) 0/22 (0.0) 1.86 (0.08 to 43.87) N/E
Excision NOS 12 3 101 232 3716/27 546 (13.5) 182 711/3 073 686 (5.9) 2.05 (1.61 to 2.60) <0.001 (96)
Ablation NOS 5 588 949 430/6482 (6.6) 26 534/582 467 (4.6) 1.45 (1.26 to 1.67) 0.19 (35)
Treatment NOS 3 41 401 44/350 (12.6) 1979/41 051 (4.8) 2.20 (1.28 to 3.78) 0.07 (62)
all treatment types v internal (pre-treatment pregnancies)
Overall 14 83 528 3117/22 121 (14.1) 3949/61 407 (6.4) 1.42 (1.01 to 1.99) <0.001 (89)
CKC 3 1430 39/347 (11.2) 38/1083 (3.5) 1.79 (0.81 to 3.95) 0.15 (47)
LC 2 161 8/87 (9.2) 3/74 (4.1) 1.65 (0.11 to 23.58) 0.06 (7)
LLETZ 5 3331 192/1524 (12.6) 178/1807 (9.9) 1.21 (0.73 to 2.01) 0.002 (77)
LA 1 226 16/129 (12.4) 10/97 (10.3) 1.20 (0.57 to 2.53) N/E
CT 1 180 3/115 (2.6) 2/65 (3.1) 0.85 (0.15 to 4.94) N/E
Excision NOS 3 78 200 2859/19 919 (14.3) 3718/58 281 (6.4) 1.65 (0.88 to 3.08) <0.001 (96)
all treatment types v internal (self matching)
Overall 7 2916 157/1458 (10.8) 103/1458 (7.1) 1.52 (1.17 to 1.97) 0.36 (9)
LC 2 354 12/177 (6.8) 9/177 (5.1) 1.30 (0.56 to 3.06) 0.42 (0)
LLETZ 1 516 31/258 (12.0) 17/258 (6.6) 1.82 (1.04 to 3.21) N/E
Excision NOS 3 1922 104/961 (10.8) 72/961 (7.5) 1.46 (0.89 to 2.39) 0.08 (60)
Treatment NOS 1 124 10/62 (16.1) 5/62 (8.1) 2.00 (0.73 to 5.51) N/E
all treatment types v untreated colposcopy+/−biopsy
Overall 13 74 958 2033/23 123 (8.8) 3119/51 835 (6.0) 1.27 (1.14 to 1.41) <0.001 (55)
CKC 2 265 25/107 (23.4) 18/158 (11.4) 1.76 (1.01 to 3.08) 0.83 (0)
LC 1 177 20/105 (19.0) 9/72 (12.5) 1.52 (0.74 to 3.15) N/E
LLETZ 9 39 249 877/10 441 (8.4) 1511/28 808 (5.2) 1.33 (1.11 to 1.6) 0.02 (55)
LA 2 3326 115/1228 (9.4) 182/2098 (8.7) 1.05 (0.84 to 1.31) 0.45 (0)
RD 1 2150 109/760 (14.3) 123/1390 (8.8) 1.62 (1.27 to 2.06) N/E
Excision NOS 5 20 321 756/7933 (9.5) 961/12 388 (7.8) 1.23 (1.07 to 1.41) 0.2 (33)
Ablation NOS 2 9470 131/2549 (5.1) 315/6921 (4.6) 1.00 (0.74 to 1.36) 0.18 (45)
all treatment types v untreated hsil
Overall 3 3764 364/3022 (12.0) 58/742 (7.8) 1.37 (0.85 to 2.19) 0.05 (53)
CKC 1 103 7/67 (10.4) 1/36 (2.8) 3.76 (0.48 to 29.39) N/E
NETZ 1 109 17/71 (23.9) 2/38 (5.3) 4.55 (1.11 to 18.66) N/E
LLETZ 1 881 55/572 (9.6) 12/309 (3.9) 2.48 (1.35 to 4.55) N/E
Excision NOS 2 2275 247/1955 (12.6) 38/319 (11.9) 1.06 (0.71 to 1.59) 0.24 (28)
Ablation NOS 2 397 38/357 (10.6) 5/40 (12.5) 0.68 (0.28 to 1.68) 0.87 (0)
untreated women v general population
Overall 17 4 359 362 6261/105 660 (5.9) 237 203/4 253 702 (5.6) 1.24 (1.14 to 1.35) <0.001 (71)
Pregnancies before 
treatment
12 3 134 087 3893/60 543 (6.4) 176 453/3 073 544 (5.7) 1.26 (1.08 to 1.45) 0.03 (49)
Untreated 
colposcopy+/−biopsy
4 1 046 823 2310/44 375 (5.2) 49 646/1 002 448 (5.0) 1.22 (1.11 to 1.34) 0.01 (74)
Untreated HSIL 3 178 452 58/742 (7.8) 11104/177 710 (6.2) 1.40 (0.94 to 2.1) 0.08 (59)
CKC=cold knife conisation; CT=cryotherapy; HSIL=high grade squamous intraepithelial lesion; LA=laser ablation; LC=laser conisation; LLETZ=large loop excision of transformation zone;  
N/E=not eligible; NETZ=needle excision of transformation zone; NOS=not otherwise specified; RD=radical diathermy.
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based study raised concerns that less radical treatment 
could increase the risk of invasion after treatment.136 137 
Although the decreased number of hysterectomies could 
explain this increase, the move to less radical local con-
servative treatments is another plausible explanation. 
Additionally, since the first documentation of the repro-
ductive risk associated with treatment almost a decade 
ago,1  subsequent observational studies and even 
meta-analyses reached contradictory conclusions2-4 16-19 
and initiated debates within the scientific community. 
With some authors raising concerns that the progressive 
reduction in the radicality of treatment has led to 
increased risk of future of invasion,136 137  and others 
advocating the move to less radical techniques like laser 
ablation for the prevention of future perinatal morbidity 
and mortality associated with treatment,138  high quality 
synthesis of the evidence had become an urgent unmet 
need. Some of the previous small meta-analyses had 
methodological flaws and attempted analysis of individ-
ual treatment techniques or subgroups, thereby minimis-
ing the validity of their findings in context with the rest of 
the literature.16-18 All the published meta-analyses failed 
to analyse the data according to major confounders and 
stratifiers of risk, the comparison group, and the depth of 
the excision. Although Bruinsma and Quinn first 
approached the comparison group as a possible con-
founder, data on the depth and dimensions of the treat-
ment were not available.4
Preterm birth is a major cause of neonatal death and 
disability and represents an enormous cost to health 
services and society. While pregnant, these women 
with a history of cervical treatment make up a large pro-
portion of referrals to specialist preterm labour preven-
tion clinics. These referrals have increased from almost 
none in 1999, to more than 40% in 2012.139  Ultrasound 
directed surveillance is labour intensive, costly, and can 
be associated with maternal anxiety, more so because 
85% of women after excision are effectively low risk and 
will deliver at term.14
With rapidly accumulating evidence correlating cervi-
cal treatment to adverse reproductive morbidity, quanti-
fication of the comparative obstetric morbidity for 
different treatment techniques and cone depths is 
required to assist clinicians’ decision making and coun-
selling. The results of our meta-analysis will allow clini-
cians, patients, and policy makers to balance the 
absolute increase in reproductive morbidity with increas-
ing treatment radicality. Patients should be informed 
that treatment increases the risk of preterm birth com-
pared with having CIN only, but the absolute increase in 
risk in small type 1 excisions is likely to be low, if any.
Furthermore, the quantified individual risk stratified 
by treatment and cone depth could allow obstetricians 
to select women considered to be at high risk of preterm 
birth who would benefit from intensive surveillance 
antenatally and minimise the unnecessary interventions 
for those at low risk. The antenatal management of 
women after treatment has been inconsistent and 
largely unit or clinician dependent.30  The risks and ben-
efits associated with various interventions in pregnant 
women with a history of cervical treatment have not 
been fully assessed in properly designed studies.140 
Future research should assess their value in this distinct 
clinical group and devise a logical prevention strategy.
Conclusion
Women with CIN have a higher baseline risk of preterm 
birth than women from the general population. Local 
cervical treatment for preinvasive or early invasive dis-
ease further increases the risk, more so for excisional 
but also for ablative techniques. The risk of preterm 
birth increases with increasing cone depth (and vol-
ume) and techniques that remove or destroy larger 
parts of the cervix. The increase in risk for small exci-
sions compared with having CIN is likely to be small, if 
any; more data are required.
In the decision to treat women of reproductive age, 
every effort should be made to perform a local treat-
ment that will optimise the chances of a healthy preg-
nancy without compromising the completeness of the 
local treatment. Quality assurance in treatment of dis-
ease should include audit of dimensions of excisional 
specimens and persistent disease rates to ensure that 
treatment depth is kept to acceptable parameters (that 
is, at least 8 mm to include the crypts) and that oncolog-
ical outcomes are not compromised.
Future research should investigate whether women 
who have preinvasive cervical disease are susceptible to 
both the disease and preterm birth, or whether HPV 
induced disease alone is the principal factor in increas-
ing premature delivery. It is likely that a combination of 
immunological and other factors play a role. The uptake 
of prophylactic vaccination has been mixed in the 
developed world and minimal in low income countries. 
The impact of cervical treatment will continue to be rel-
evant for many decades, and therefore robust clinical 
research in this field should remain a priority.
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